811 material Form 8-K filings that 685 companies we cover made with the SEC in April 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Sphere Entertainment's subsidiary MSGN Holdings L.P. agreed by email on April 21, 2025 to a three-day extension of a forbearance agreement with its lenders, which pauses lender remedies over a missed term loan payment and a budget delivery requirement. The forbearance period now runs until 11:59 p.m. E.T. on April 24, 2025, or an earlier termination event, unless extended further. The filing shows the lenders have not yet been paid and the arrangement remains short-term, which matters to shareholders because the financing situation is still unresolved.
Forbearance period extended by three days to 11:59 p.m. E.T. on April 24, 2025
Extension agreed by email on April 21, 2025, with the forbearance originally set to expire November 8, 2024
Underlying issue: MSGN L.P. did not pay term loan principal at its October 11, 2024 maturity
Separate condition: failure to deliver MSG Networks' budget by March 31, 2025 would be an event of default if not cured by April 30, 2025
Western Alliance Bancorporation reported first quarter 2025 net income of $199.1 million and diluted earnings per share of $1.79, up from a year earlier but down from the fourth quarter of 2024. The company also reappointed Kenneth A. Vecchione as President and Chief Executive Officer, effective April 15, 2025, ending the temporary leave under which Dale Gibbons had served as interim CEO.
Net income of $199.1 million, up 12.2% from $177.4 million a year earlier and down 8.2% from $216.9 million in the fourth quarter of 2024.
Diluted earnings per share of $1.79, compared with $1.60 a year earlier and $1.95 in the fourth quarter of 2024.
Net revenue of $778.0 million, up 6.8% year over year and down 7.2% from the fourth quarter of 2024.
Kenneth A. Vecchione reappointed President and CEO effective April 15, 2025; Dale Gibbons remains Vice Chair and Chief Financial Officer.
Hexcel reported first-quarter 2025 sales of $457 million, down 3.3% from a year earlier, and GAAP diluted EPS of $0.35 versus $0.43. The company lowered its full-year 2025 guidance for sales, adjusted EPS, and free cash flow, citing supply chain delays in commercial aircraft production rate ramps, particularly on the Airbus A350. Lower guidance means shareholders should expect weaker 2025 results than previously forecast.
Q1 2025 net sales were $456.5 million, down from $472.3 million; Commercial Aerospace sales fell 6.4% to $280.1 million.
Q1 2025 adjusted diluted EPS was $0.37, versus $0.44 a year earlier; GAAP diluted EPS was $0.35, versus $0.43.
2025 sales guidance was cut to $1.88 billion to $1.95 billion from $1.95 billion to $2.05 billion.
2025 adjusted diluted EPS guidance was cut to $1.85 to $2.05 from $2.05 to $2.25; free cash flow guidance was lowered to approximately $190 million from greater than $220 million.
Medpace reported first-quarter 2025 revenue of $558.6 million and GAAP diluted EPS of $3.67, both up from the prior-year quarter, and issued 2025 guidance of $2.140 billion to $2.240 billion in revenue and $12.26 to $13.04 in diluted EPS. Its board also raised the stock repurchase program by $1.0 billion on April 17, 2025, and the company amended its $600 million unsecured credit facility with PNC Bank.
Q1 2025 revenue was $558.6 million, up 9.3% from $511.0 million; GAAP net income was $114.6 million, or $3.67 per diluted share, versus $3.20 a year earlier.
Net new business awards fell 18.8% to $500.0 million, giving a 0.90x book-to-bill ratio; backlog decreased 2.1% to $2,846.0 million.
Board approved a $1.0 billion increase to the stock repurchase program on April 17, 2025; $344.8 million remained under the program at March 31, 2025.
Full-year 2025 guidance: revenue of $2.140 billion to $2.240 billion and GAAP diluted EPS of $12.26 to $13.04.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.